Our mission is to provide the Premier collection of well-characterized models and services for drug discovery to help our clients reduce the attrition rate of candidate compounds by improving molecule selection, as well as identifying patients who will benefit most from a treatment regimen.
CrownBio will launch a large initiative to test "1,000 drugs in 10,000" PDX models. The invaluable data and information that will results will help transform cancer from an acute, deadly disease to a manageable chronic condition
Comparably data clearly shows that a focused mission statement and cohesive core company values are vital to maintaining employee alignment.